Prof. Jia Fan 樊嘉
Oncology
Zhongshan Hospital, Fudan University, Shanghai
Public profile Compiled from public sources. We do not work directly with this doctor, but we can find a specialist in this field to review your case.
Get a specialist opinionCurrent positions
- Academician, Chinese Academy of Sciences
- Honorary President, Zhongshan Hospital, Fudan University
Checked against a public report (2026-03). Positions change; the hospital's website is the final word.
Clinical focus: Surgical treatment of liver tumors, including hepatocellular carcinoma. Focus areas include precise resection, comprehensive management of portal vein tumor thrombus, prevention of recurrence and metastasis, and multidisciplinary care for hepatobiliary tumors.
Conditions and procedures: Hepatocellular carcinoma, Liver tumors, Portal vein tumor thrombus, Hepatobiliary tumors
Compiled from public information; not confirmed with the hospital or the doctor.
Name order: in Chinese the family name comes first (Fan Jia). Papers usually list the name as Jia Fan.
Selected publications
21 first- or senior-author papers on PubMed where the author's own affiliation is this hospital (21 since 2016), counted among the 200 most recent matching papers. Most recent:
- Science, 2026 (senior author): Spatiotemporal multiomics uncover tumor ecosystem dynamics during metastatic colonization. PubMed 42531396
- Cancer Immunol Immunother, 2026 (senior author): AdvanTIG-206: a phase II, randomized study of ociperlimab plus tislelizumab and BAT1706 (bevacizumab biosimilar) versus tislelizumab and BAT1706 in first-line hepatocellular carcinoma. PubMed 42047833
- Cell Rep Med, 2026 (senior author): Robust transcriptomic hallmarks targeting intratumor heterogeneity in intrahepatic cholangiocarcinoma. PubMed 41916296
- Signal Transduct Target Ther, 2026 (senior author): Activation of Nerve Growth Factor signaling limits the response to lenvatinib in hepatocellular carcinoma. PubMed 41946693
- Hepatology, 2026 (senior author): CAD manipulates tumor intrinsic DHO/UBE4B/NF-κB pathway and fuels macrophage cross-talk, promoting HCC metastasis. PubMed 40073276
- Cancer Cell, 2026 (senior author): Integrative proteogenomic analysis provides molecular insights and clinical significance in gallbladder cancer. PubMed 41512870
- Liver Cancer, 2025 (senior author): China Liver Cancer Guidelines for the Diagnosis and Treatment of Hepatocellular Carcinoma (2024 Edition). PubMed 41063733
- Lancet Oncol, 2025 (senior author): Conversion therapy of tislelizumab plus lenvatinib and GEMOX in unresectable locally advanced biliary tract cancer (ZSAB-TransGOLP): a multicentre, prospective, phase 2 study. PubMed 40889502
Each paper was checked automatically: the author listed with this name must give this hospital as their affiliation; because this name is common, the affiliation must also name the specialty. See the full PubMed search.
This profile has not been reviewed by the doctor. How we build this directory.
Want a specialist to review your case?
Send your records. We find a specialist in this field who can review your case and recommend a treatment plan.
Get a specialist opinion